“The American Diabetes Council was formed for the sole purpose of disseminating information to the public. Information that can and does save lives. The council is a non-profit organization that works with various companies to assist in spreading the word of alternative treatments for many ailments/diseases. The council only works with companies that have track records that are impeccable and backed by the testimonials of their customers.” (http://americandiabetescouncil.com/About.asp; accessed 7/6/05)
The American Diabetes Council endorses a single product: Angioprim, which is made by Ionetics Corporation, a wholly owned subsidiary of GMC Holdings Corporation. (“GMC Holdings Announces a 3 for 1 Forward Split for Shareholders as of March 10th, 2002,” Business Wire, March 1, 2002, Friday) The vast majority of the American Diabetes Council webpage is devoted to discussing the merits of Angioprim.
In 2005, the FDA issued a warning to Ionetics Corporation stating that Angioprim, which has never been approved by the FDA, is a drug under the Federal Food, Drug, and Cosmetic Act because its labeling claims that Angioprim “is intended for use in the cure, mitigation, treatment, or prevention of disease.” The FDA letter then lists specific claims from the websites associated with Angioprim that violate the Act. (http://www.fda.gov/foi/warning_letters/g5223d.htm; accessed 7/6/05)
According to the National Council Against Health Fraud, the drug websites mentioned in the FDA’s warning letter (www.agioprim.com, www.anginacure.com, and www.yourticker.com) have not been corrected. They still contain the offending claims about the efficacy of Angioprim. (http://www.ncahf.org/digest05/05-12.html; accessed 7/6/05)
The Council’s webpage, www.americandiabetescouncil.com, is registered to Slocumb and Associates (now Central Marketing Solutions), and Jack Slocumb is the administrative contact and technical contact. (http://www.networksolutions.com/en_US/whois/results.jhtml;jsessionid= SDFNNAXKQIWPKCWMEAQCFFA?whoistoken=25&_requestid=876639; accessed 7/8/05) Jack Slocumb is listed as a representative on the Angioprim website. (http://angioprim.com/Home/Contact.asp?RepID=10001&Home=Y; accessed 7/8/05)
(See also the American Heart Council)